Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study
This study evaluated the nephroprotective potential of dapagliflozin and silymarin, alone and in combination, against cisplatin-induced kidney damage in female Wistar rats. Cisplatin was administered at 3 mg/kg weekly to all groups except the normal controls, with treatments of silymarin (50 mg/kg/d...
Saved in:
Main Authors: | Shakta Mani Satyam, Laxminarayana Kurady Bairy, Abdul Rehman, Anuradha Asokan Nair, Mohamed Farook, Nirmal Nachiketh Binu, Sofiya Khan, Mohamed Yehya, Mohammed Moin Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Sci |
Subjects: | |
Online Access: | https://www.mdpi.com/2413-4155/7/2/59 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of nanodiamond–doxorubicin complexes on human breast adenocarcinoma cell lines
by: Kitsakorn Locharoenrat
Published: (2019-12-01) -
VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01) -
LOCAL HYPERTHERMIA IN THE COMBINED TREATMENT OF LOCALLY ADVANCED SOFT TISSUE SARCOMAS
by: A. L. Zubarev, et al.
Published: (2016-02-01) -
Pseudohypoxia-Stabilized HIF2α Transcriptionally Inhibits <i>MNRR1</i>, a Druggable Target in MELAS
by: Neeraja Purandare, et al.
Published: (2025-07-01) -
Repurposing piroxicam enhances the antineoplastic effects of docetaxel and enzalutamide in prostate cancer cells using 2D and 3D in vitro culture models
by: Amani Yehya, et al.
Published: (2025-07-01)